All Stories

  1. Novel Gd-DTPA-peptide for targeted breast tumor magnetic resonance imaging

    Article • Biomedicine & Pharmacotherapy, September 2024, Elsevier

    Davood Beiki

  2. Recent Clinical Implications of FAPI

    Article • Clinical Nuclear Medicine, July 2024, Wolters Kluwer Health

    Davood Beiki

  3. Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer

    Article • Pharmaceutics, July 2024, MDPI AG

    Davood Beiki

  4. Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study

    Article • Nuclear Medicine Communications, January 2024, Wolters Kluwer Health

    Davood Beiki

  5. Diagnostic value of [68Ga]Ga-Pentixafor versus [18F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study

    Article • Nuclear Medicine Communications, June 2023, Wolters Kluwer Health

    Davood Beiki

  6. Internal dosimetry of 64Cu-DOX-loaded microcapsules by Monte Carlo method

    Article • Applied Radiation and Isotopes, June 2023, Elsevier

    Davood Beiki

  7. X-ray-based cancer diagnosis and treatment methods

    Article • January 2023, Elsevier

    Davood Beiki

  8. Nuclear Imaging in Patients with Differentiated Thyroid Cancer and Negative Radioactive Io-dine Scan

    Article • Iranian South Medical Journal, December 2022, CMV Verlag

    Davood Beiki

  9. Amino-modified-silica-coated gadolinium-copper nanoclusters, conjugated to AS1411 aptamer and radiolabeled with technetium-99 m as a novel multimodal imaging agent

    Article • Bioorganic Chemistry, August 2022, Elsevier

    Davood Beiki

  10. Development of 64Cu-DOX/DOX-loaded chitosan-BSA multilayered hollow microcapsules for selective lung drug delivery

    Article • Journal of Drug Delivery Science and Technology, July 2022, Elsevier

    Davood Beiki

  11. 18F‐FDG MicroPET and MRI Targeting Breast Cancer Mouse Model with Designed Synthesis Nanoparticles

    Article • Journal of Nanomaterials, January 2022, Wiley

    Davood Beiki

  12. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer

    Article • Clinical Nuclear Medicine, November 2020, Wolters Kluwer Health

    Davood Beiki

  13. 177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: Biological evaluation and preclinical study

    Article • Bioorganic Chemistry, September 2020, Elsevier

    Davood Beiki

  14. Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation

    Article • Bioorganic Chemistry, September 2020, Elsevier

    Davood Beiki

  15. Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent

    Article • International Journal of Polymeric Materials, July 2020, Taylor & Francis

    Davood Beiki

  16. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen

    Article • Bioorganic Chemistry, June 2020, Elsevier

    Davood Beiki

  17. Synthesis, biological evaluation and preclinical study of a novel 99mTc-peptide: A targeting probe of amyloid-β plaques as a possible diagnostic agent for Alzheimer’s disease

    Article • Bioorganic Chemistry, June 2020, Elsevier

    Davood Beiki

  18. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe

    Article • International Journal of Biological Macromolecules, April 2020, Elsevier

    Davood Beiki

  19. Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed αvβ3 Integrin Receptors in Non-Small-Cell Lung Cancer

    Article • Contrast Media & Molecular Imaging, March 2020, Wiley

    Davood Beiki

  20. Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors

    Article • Bioorganic Chemistry, January 2020, Elsevier

    Davood Beiki

  21. Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy

    Article • Biophysical Reviews, November 2019, Springer Science + Business Media

    Davood Beiki

  22. Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18 F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis

    Article • Cancer Biotherapy & Radiopharmaceuticals, June 2019, SAGE Publications

    Davood Beiki

  23. 68Ga-radiolabeled nanoparticles for PET/MR imaging of breast cancer

    Article • International Journal of Nanomedicine, April 2019, Dove Medical Press

    Fatemeh Atyabi, Prof Amir R Jalilian, Davood Beiki, Maliheh Hajiramezanali

  24. Development of a novel 68Ga-dextran carboxylate derivative for blood pool imaging

    Article • Radiochimica Acta, March 2019, De Gruyter

    Davood Beiki

  25. Synthesis, characterization, and in vitro and in vivo 68Ga radiolabeling of thiosemicarbazone Schiff base derived from dialdehyde dextran as a promising blood pool imaging agent

    Article • International Journal of Biological Macromolecules, March 2019, Elsevier

    Davood Beiki

  26. Automated Interpretation of Myocardial Perfusion Images with Multilayer Perceptron Network as a Decision Support System

    Article • Journal of Medical Imaging and Health Informatics, December 2018, American Scientific Publishers

    Davood Beiki

  27. Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy

    Article • ACS Applied Materials & Interfaces, September 2017, American Chemical Society (ACS)

    Davood Beiki

  28. β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors

    Article • Current Radiopharmaceuticals, August 2017, Bentham Science Publishers

    Davood Beiki

  29. Chelator-free radiolabeling of dextran with 68Ga for PET studies

    Article • Journal of Radioanalytical and Nuclear Chemistry, January 2017, Springer Science + Business Media

    Davood Beiki

  30. Optimized production, quality control, biological evaluation and PET/CT imaging of 68Ga-PSMA-617 in breast adenocarcinoma model

    Article • Radiochimica Acta, January 2017, De Gruyter

    Prof Amir R Jalilian, Davood Beiki

  31. Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes

    Article • Nuclear Medicine Communications, January 2017, Wolters Kluwer Health

    Davood Beiki

  32. Production of 68Ga-citrate Based on a SnO2 Generator for Short-Term Turpentine Oil-Induced Inflammation Imaging in Rats

    Article • Current Radiopharmaceuticals, December 2016, Bentham Science Publishers

    Davood Beiki

  33. Erratum to “Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran” [Semin Nucl Med 2016;46:340-358]

    Article • Seminars in Nuclear Medicine, November 2016, Elsevier

    Davood Beiki

  34. Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging

    Article • Nuclear Science and Techniques, October 2016, Springer Science + Business Media

    Davood Beiki

  35. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran

    Article • Seminars in Nuclear Medicine, July 2016, Elsevier

    Davood Beiki

  36. Efficacy and Complications of Samarium153-EDTMP Added to Palliative Local Radiotherapy for Bone Metastases

    Article • Brachytherapy, May 2016, Elsevier

    Davood Beiki

  37. The value of 18F‐fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta‐analysis

    Article • Journal of Gastroenterology and Hepatology, April 2016, Wiley

    Davood Beiki

  38. 18FDG-labeled LIKKPF: a PET tracer for apoptosis imaging

    Article • Journal of Radioanalytical and Nuclear Chemistry, March 2016, Springer Science + Business Media

    Davood Beiki

  39. Preparation and Quality Control of 111In-Plerixafor for Chemokine Receptor CXCR4

    Article • Recent Patents and Topics on Imaging, December 2015, Bentham Science Publishers

    Prof Amir R Jalilian, Davood Beiki

  40. Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders

    Article • Annals of Nuclear Medicine, November 2015, Springer Science + Business Media

    Davood Beiki

  41. Folate therapy improves the stress-to-rest mean LV volume ratio in myocardial perfusion imaging in patients with diabetes

    Article • Annals of Nuclear Medicine, July 2015, Springer Science + Business Media

    Davood Beiki

  42. Development of a 99mTc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors

    Article • Annals of Nuclear Medicine, July 2015, Springer Science + Business Media

    Davood Beiki

  43. HYNIC a bifunctional prosthetic group for the labelling of peptides with 99mTc and 18FDG

    Article • Journal of Radioanalytical and Nuclear Chemistry, June 2015, Springer Science + Business Media

    Davood Beiki

  44. Development of 68Ga ethyl cysteinate dimer for PET studies

    Article • Journal of Radioanalytical and Nuclear Chemistry, May 2015, Springer Science + Business Media

    Davood Beiki

  45. Optimized production and quality control of 68Ga-EDTMP for small clinical trials

    Article • Annals of Nuclear Medicine, April 2015, Springer Science + Business Media

    Davood Beiki

  46. Dosimetric evaluation of 153Sm-EDTMP, 177Lu-EDTMP and 166Ho-EDTMP for systemic radiation therapy: Influence of type and energy of radiation and half-life of radionuclides

    Article • Radiation Physics and Chemistry, March 2015, Elsevier

    Davood Beiki

  47. Preparation and Evaluation of 68Ga-ECC as a PET Renal Imaging Agent

    Article • Nuclear Medicine and Molecular Imaging, February 2015, Springer Science + Business Media

    Davood Beiki

  48. Assessment of prognostic value of semiquantitative parameters on gated single photon emission computed tomography myocardial perfusion scintigraphy in a large middle eastern population

    Article • Indian Journal of Nuclear Medicine, January 2015, Medknow

    Davood Beiki

  49. Diffuse pulmonary uptake of bone-seeking radiotracer in bone scintigraphy of a rare case of pulmonary alveolar microlithiasis

    Article • Indian Journal of Nuclear Medicine, January 2015, Medknow

    Davood Beiki

  50. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma

    Article • Nuclear Medicine Communications, August 2014, Wolters Kluwer Health

    Davood Beiki

  51. Synthesis and evaluation of [67Ga]-AMD3100; A novel imaging agent for targeting chemokine receptor CXCR4

    Article • Nuclear Medicine and Biology, August 2014, Elsevier

    Davood Beiki

  52. Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent

    Article • Journal of Radioanalytical and Nuclear Chemistry, July 2014, Springer Science + Business Media

    Davood Beiki

  53. The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I‐MIBG accompanied by ASCT for high‐risk and relapsed neuroblastoma: A pilot study

    Article • Pediatric Transplantation, May 2014, Wiley

    Davood Beiki

  54. Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents

    Article • Journal of Radioanalytical and Nuclear Chemistry, April 2014, Springer Science + Business Media

    Davood Beiki

  55. Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts

    Article • Radiochimica Acta, March 2014, De Gruyter

    Davood Beiki

  56. Synthesis and Evaluation of [67Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4

    Article • Scientia Pharmaceutica, January 2014, MDPI AG

    Davood Beiki

  57. Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging

    Article • Journal of Radioanalytical and Nuclear Chemistry, November 2013, Springer Science + Business Media

    Davood Beiki

  58. Preparation and evaluation of a new neurotensin analog labeled with 99mTc for targeted imaging of neurotensin receptor positive tumors

    Article • Journal of Radioanalytical and Nuclear Chemistry, October 2013, Springer Science + Business Media

    Davood Beiki

  59. Comparison [3H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation

    Article • Nuclear Medicine and Biology, October 2013, Elsevier

    Davood Beiki

  60. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?

    Article • Nuclear Medicine Communications, August 2013, Wolters Kluwer Health

    Davood Beiki

  61. Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trial

    Article • DARU Journal of Pharmaceutical Sciences, January 2013, Springer Science + Business Media

    Davood Beiki

  62. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer

    Article • Nuclear Medicine Communications, October 2012, Wolters Kluwer Health

    Davood Beiki

  63. Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent

    Article • Journal of Radioanalytical and Nuclear Chemistry, August 2012, Springer Science + Business Media

    Davood Beiki

  64. Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma

    Article • Nuclear Medicine Communications, March 2012, Wolters Kluwer Health

    Davood Beiki

  65. Assessment of genetic mutations in the XRCC2 coding region by high resolution melting curve analysis and the risk of differentiated thyroid carcinoma in Iran

    Article • Genetics and Molecular Biology, February 2012, FapUNIFESP (SciELO)

    Davood Beiki

  66. Renal Axis Deviation in Urinary Tract Abnormalities of Children

    Article • Clinical Nuclear Medicine, December 2011, Wolters Kluwer Health

    Davood Beiki

  67. Radioiodine Therapy for Hyperthyroidism

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2011, New England Journal of Medicine (NEJM/MMS)

    Davood Beiki

  68. Incidence of Second Primary Malignancies During a Long-term Surveillance of Patients With Differentiated Thyroid Carcinoma in Relation to Radioiodine Treatment

    Article • Clinical Nuclear Medicine, April 2011, Wolters Kluwer Health

    Davood Beiki

  69. An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene

    Article • Cancer Epidemiology, February 2011, Elsevier

    Davood Beiki

  70. Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report

    Article • Journal of Medical Case Reports, October 2010, Springer Science + Business Media

    Davood Beiki

  71. Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor

    Article • International Urology and Nephrology, October 2009, Springer Science + Business Media

    Davood Beiki

  72. Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells

    Article • Nuclear Medicine and Biology, October 2009, Elsevier

    Dr Amirhossein Ahmadi, Seyed Jalal HOSSEINIMEHR, Davood Beiki

  73. Manifestations of Ollier's disease in a 21-year-old man: a case report

    Article • Journal of Medical Case Reports, May 2009, Springer Science + Business Media

    Davood Beiki

  74. The radiotracer99m Tc-MIBI is not genotoxic for human peripheral blood lymphocytes at diagnostic radioactive dose

    Article • Genetics and Molecular Research, January 2009, Genetics and Molecular Research

    Seyed Jalal HOSSEINIMEHR, Dr Amirhossein Ahmadi, Davood Beiki

  75. Single Tc99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion

    Article • The International Journal of Cardiovascular Imaging, June 2008, Springer Science + Business Media

    Davood Beiki

  76. Assessment of the Accuracy of Lacrimal Scintigraphy Based on a Prospective Analysis of Patients' Symptomatology

    Article • Orbit, January 2008, Taylor & Francis

    Davood Beiki

  77. The Effect of High-Dose Radioiodine Treatment on Lacrimal Gland Function in Patients With Differentiated Thyroid Carcinoma

    Article • Clinical Nuclear Medicine, September 2007, Wolters Kluwer Health

    Davood Beiki

  78. Quantitative Assessment of Dacryoscintigraphic Images in the Evaluation of Epiphora

    Article • Orbit, January 2007, Taylor & Francis

    Davood Beiki

  79. Comparison of MRI findings with traditional criteria in diagnosis of Pendred syndrome

    Article • International Journal of Audiology, January 2007, Taylor & Francis

    Dr. Ozra Tabatabaei-Malazy, Davood Beiki

  80. A correlative study comparing current different methods of calculating left ventricular ejection fraction

    Article • Nuclear Medicine Communications, January 2007, Wolters Kluwer Health

    Davood Beiki

  81. Brain Perfusion Single Photon Emission Computed Tomography Findings in Patients with Posttraumatic Anosmia and Comparison with Radiological Imaging

    Article • American Journal of Rhinology and Allergy, November 2006, SAGE Publications

    Davood Beiki

  82. 238 Lacrimal gland function in patients with thyroid cancer treated with radioactive iodine

    Article • Radiotherapy and Oncology, September 2006, Elsevier

    Davood Beiki

  83. Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

    Article • Nuclear Medicine Communications, July 2006, Wolters Kluwer Health

    Davood Beiki

  84. Correlative study comparing current different methods of calculating left ventricular ejection fraction

    Article • Journal of Molecular and Cellular Cardiology, June 2006, Elsevier

    Davood Beiki

  85. A5. Correlative study comparing current different methods of calculating left ventricular ejection fraction

    Article • Journal of Molecular and Cellular Cardiology, June 2006, Elsevier

    Davood Beiki

  86. Frequency and severity of myocardial perfusion abnormalities using Tc-99m MIBI SPECT in cardiac syndrome X

    Article • BMC Nuclear Medicine, February 2006, Springer Science + Business Media

    Davood Beiki

  87. A preliminary study of neuroSPECT evaluation of patients with post-traumatic smell impairment

    Article • BMC Nuclear Medicine, November 2005, Springer Science + Business Media

    Davood Beiki

  88. 119 Specificity of single photon emission computed tomography versus conventional bone scintigraphy for differentiating malignant from benign vertebral lesions in cancer patients

    Article • Radiotherapy and Oncology, September 2005, Elsevier

    Davood Beiki

  89. γ-scintigraphic evaluation of enteric-coated capsules containing chitosan-brilliant blue gel beads as hydrophilic model for colon drug delivery

    Article • Journal of Drug Delivery Science and Technology, January 2005, Elsevier

    Davood Beiki

  90. Synthesis of 1‐β‐D‐(5‐Deoxy‐5‐iodoarabinofuranosyl)‐2‐nitroimidazole (β‐IAZA): A Novel Marker of Tissue Hypoxia.

    Article • ChemInform, August 2003, Wiley

    Davood Beiki

  91. Synthesis of 1-.BETA.-D-(5-Deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (.BETA.-IAZA): A Novel Marker of Tissue Hypoxia.

    Article • Chemical and Pharmaceutical Bulletin, January 2003, Pharmaceutical Society of Japan

    Davood Beiki

  92. Increased selectivity in inflammatory site identification via labelling of IgG with N‐succinimidyl‐4‐[125I]iodobenzoate

    Article • Journal of Labelled Compounds and Radiopharmaceuticals, August 2002, Wiley

    Davood Beiki

  93. Synthesis of β-azomycin nucleosides: 1-(β-d-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole (β-2-IAZA), a novel marker of tissue hypoxia

    Article • Tetrahedron Letters, June 2002, Elsevier

    Davood Beiki

  94. A new and simple synthesis of N‐succinimidyl‐4‐[127/125I]iodobenzoate involving a microwave ‐ accelerated iodination step

    Article • Journal of Labelled Compounds and Radiopharmaceuticals, March 2001, Wiley

    Davood Beiki

  95. Nuklearmedizin - NuclearMedicine

    Article • Nuklearmedizin - NuclearMedicine, Thieme Publishing Group

    Davood Beiki